CEACAM5 and neoplasm: After six courses of chemotherapy, tumor markers, AST, and ALT levels were decreased (CEA, 10.9 ng/mL; CA19-9, 16.3 U/mL; AFP, 72.6 ng/mL; AST 43 IU/L; ALT, 16 IU/L).